FIGURE

Fig. 3

ID

ZDB-FIG-250813-31

Publication

Zimmerman et al., 2025 - Investigating Psychopharmaceutical Effects on Early Vertebrate Development Using a Zebrafish Model System

Other Figures

All Figure Page

Back to All Figure Page

Fig. 3

(A–E) Morphological measurements of zebrafish following exposure to AY9944 and psychopharmaceuticals. (A) Measurements i-iii were taken from the lateral view. Measurement i: eye width, measures the anterior portion of the eye to the most posterior side of the eye. Measurement ii: rump length, measures the anterior portion of the eye to the anus. Measurement iii: standard length, measures the anterior portion of the eye to the most posterior portion of the tail. Measurement iv: Distance between eyes measures the distance along the most lateral position of one to the other eye (dorsal view). Scale bar: 100 µm. (B) Eye width (C) Distance between the eyes (D) Rump length (E) Standard length. N ≥ 4 with at least 30 fish per trial. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, determined by one-way ANOVA followed by Tukey’s post hoc HSD. VEH = 0.1% DMSO, AY9944 = positive control, CAR = Cariprazine, ARI = Aripiprazole, TRZ = Trazodone. Error Bars = 95% confidence intervals.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ J Dev Biol